Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt) | MicrobiomeTrials← Back to trialsNCT06318260
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2024-04-08Est. Completion: 2026-07
Enrollment target: 15 participants Locations- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
Other microbiome trials you might be interested in
Transthyretin Amyloid Cardiomyopathy
The purpose of this study is to investigate the effect of eplontersen compared to placebo on the reduction of serum TTR …
Beijing, ChinaEst. completion May 13, 2026
Transthyretin Amyloid Cardiomyopathy
Transthyretin (TTR) is a protein made by the liver that helps transport thyroid hormone and vitamin A in the blood. In s…
Sankt Pölten, AustriaEst. completion Jul 15, 2027
Lumbar Spinal StenosisCardiac AmyloidosisATTR Amyloidosis Wild TypeATTR Gene MutationATTRV122I AmyloidosisCardiomyopathy, Hypertrophic
Primary objective:
To identify older adults with transthyretin cardiac amyloidosis (ATTR-CA) early in the course of the…
Beverly Hills, United StatesEst. completion May 2027